Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study

John L Keltner, Chris A. Johnson, Richard A. Levine, Juanjuan Fan, Kimberly E. Cello, Michael A. Kass, Mae O. Gordon

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective: To compare the occurrence of normal visual field (VF) test results following 2 vs 3 consecutive, abnormal, reliable test results in the Ocular Hypertension Treatment Study. Methods: The Ocular Hypertension Treatment Study is a prospective, multicenter follow-up study as part of a longitudinal randomized clinical trial. Sixty-four (68 eyes) of 1636 participants developed a VF primary open-angle glaucoma (POAG) end point. We compared the proportion of normal VF test results after a VF POAG end point among eyes whose VF abnormality was confirmed by 2 (n=9 eyes) vs 3 (n=59 eyes) consecutive, abnormal, reliable VF test results. Results: The proportion of VF test results that were normal subsequent to a VF POAG end point in eyes whose abnormality was confirmed by 2 consecutive, abnormal, reliable test results was significantly higher (73 [66%] of 110) compared with eyes whose abnormality was confirmed by 3 consecutive, abnormal, reliable test results (46 [12%] of 381) (P=.01). Conclusions: A VF POAG end point confirmed by 3 consecutive, abnormal, reliable VF test results appears to have greater specificity and stability than either 1 or 2 consecutive, abnormal, reliable VF test results. However, some eyes whose VF POAG end point was confirmed by 3 consecutive, abnormal, reliable test results nonetheless had 1 or more normal test results on follow-up.

Original languageEnglish (US)
Pages (from-to)1201-1206
Number of pages6
JournalArchives of Ophthalmology
Volume123
Issue number9
DOIs
StatePublished - Sep 2005

Fingerprint

Ocular Hypertension
Visual Field Tests
Visual Fields
Eye Abnormalities
Randomized Controlled Trials
Primary Open Angle Glaucoma

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. / Keltner, John L; Johnson, Chris A.; Levine, Richard A.; Fan, Juanjuan; Cello, Kimberly E.; Kass, Michael A.; Gordon, Mae O.

In: Archives of Ophthalmology, Vol. 123, No. 9, 09.2005, p. 1201-1206.

Research output: Contribution to journalArticle

Keltner, John L ; Johnson, Chris A. ; Levine, Richard A. ; Fan, Juanjuan ; Cello, Kimberly E. ; Kass, Michael A. ; Gordon, Mae O. / Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. In: Archives of Ophthalmology. 2005 ; Vol. 123, No. 9. pp. 1201-1206.
@article{bc5fd832e2c64f15a02ee47c5e680dac,
title = "Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study",
abstract = "Objective: To compare the occurrence of normal visual field (VF) test results following 2 vs 3 consecutive, abnormal, reliable test results in the Ocular Hypertension Treatment Study. Methods: The Ocular Hypertension Treatment Study is a prospective, multicenter follow-up study as part of a longitudinal randomized clinical trial. Sixty-four (68 eyes) of 1636 participants developed a VF primary open-angle glaucoma (POAG) end point. We compared the proportion of normal VF test results after a VF POAG end point among eyes whose VF abnormality was confirmed by 2 (n=9 eyes) vs 3 (n=59 eyes) consecutive, abnormal, reliable VF test results. Results: The proportion of VF test results that were normal subsequent to a VF POAG end point in eyes whose abnormality was confirmed by 2 consecutive, abnormal, reliable test results was significantly higher (73 [66{\%}] of 110) compared with eyes whose abnormality was confirmed by 3 consecutive, abnormal, reliable test results (46 [12{\%}] of 381) (P=.01). Conclusions: A VF POAG end point confirmed by 3 consecutive, abnormal, reliable VF test results appears to have greater specificity and stability than either 1 or 2 consecutive, abnormal, reliable VF test results. However, some eyes whose VF POAG end point was confirmed by 3 consecutive, abnormal, reliable test results nonetheless had 1 or more normal test results on follow-up.",
author = "Keltner, {John L} and Johnson, {Chris A.} and Levine, {Richard A.} and Juanjuan Fan and Cello, {Kimberly E.} and Kass, {Michael A.} and Gordon, {Mae O.}",
year = "2005",
month = "9",
doi = "10.1001/archopht.123.9.1201",
language = "English (US)",
volume = "123",
pages = "1201--1206",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study

AU - Keltner, John L

AU - Johnson, Chris A.

AU - Levine, Richard A.

AU - Fan, Juanjuan

AU - Cello, Kimberly E.

AU - Kass, Michael A.

AU - Gordon, Mae O.

PY - 2005/9

Y1 - 2005/9

N2 - Objective: To compare the occurrence of normal visual field (VF) test results following 2 vs 3 consecutive, abnormal, reliable test results in the Ocular Hypertension Treatment Study. Methods: The Ocular Hypertension Treatment Study is a prospective, multicenter follow-up study as part of a longitudinal randomized clinical trial. Sixty-four (68 eyes) of 1636 participants developed a VF primary open-angle glaucoma (POAG) end point. We compared the proportion of normal VF test results after a VF POAG end point among eyes whose VF abnormality was confirmed by 2 (n=9 eyes) vs 3 (n=59 eyes) consecutive, abnormal, reliable VF test results. Results: The proportion of VF test results that were normal subsequent to a VF POAG end point in eyes whose abnormality was confirmed by 2 consecutive, abnormal, reliable test results was significantly higher (73 [66%] of 110) compared with eyes whose abnormality was confirmed by 3 consecutive, abnormal, reliable test results (46 [12%] of 381) (P=.01). Conclusions: A VF POAG end point confirmed by 3 consecutive, abnormal, reliable VF test results appears to have greater specificity and stability than either 1 or 2 consecutive, abnormal, reliable VF test results. However, some eyes whose VF POAG end point was confirmed by 3 consecutive, abnormal, reliable test results nonetheless had 1 or more normal test results on follow-up.

AB - Objective: To compare the occurrence of normal visual field (VF) test results following 2 vs 3 consecutive, abnormal, reliable test results in the Ocular Hypertension Treatment Study. Methods: The Ocular Hypertension Treatment Study is a prospective, multicenter follow-up study as part of a longitudinal randomized clinical trial. Sixty-four (68 eyes) of 1636 participants developed a VF primary open-angle glaucoma (POAG) end point. We compared the proportion of normal VF test results after a VF POAG end point among eyes whose VF abnormality was confirmed by 2 (n=9 eyes) vs 3 (n=59 eyes) consecutive, abnormal, reliable VF test results. Results: The proportion of VF test results that were normal subsequent to a VF POAG end point in eyes whose abnormality was confirmed by 2 consecutive, abnormal, reliable test results was significantly higher (73 [66%] of 110) compared with eyes whose abnormality was confirmed by 3 consecutive, abnormal, reliable test results (46 [12%] of 381) (P=.01). Conclusions: A VF POAG end point confirmed by 3 consecutive, abnormal, reliable VF test results appears to have greater specificity and stability than either 1 or 2 consecutive, abnormal, reliable VF test results. However, some eyes whose VF POAG end point was confirmed by 3 consecutive, abnormal, reliable test results nonetheless had 1 or more normal test results on follow-up.

UR - http://www.scopus.com/inward/record.url?scp=24944591118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944591118&partnerID=8YFLogxK

U2 - 10.1001/archopht.123.9.1201

DO - 10.1001/archopht.123.9.1201

M3 - Article

VL - 123

SP - 1201

EP - 1206

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 9

ER -